News

Read the interview of our President Bernard Orlandini, along with Marc Essodaigui, CEO of Active Biomarkers and Alexandre Durand-Salmon, CEO of Banook Group.

Translational PK/PD and Model-Informed Drug Development (MIDD) of monoclonal antibodies

We are officially a member of the "La French Tech Paris-Saclay" community. An association that federates, creates connections and offers opportunities.

The independent medical publication Prescrire.org rewards Fexinidazole

Consider current and future data regulations when planning studies for your development program.

In vitro-In vivo is a strategic tool in drug developement, discover why!

Population Pharmacokinetics (PopPK), a crucial approach in drug development

We are proud to be in the Top 500 of the Les Echos / Statista ranking of "Champions de la Croissance" in France.

We participated at the FDA workshop about the development of Best Practices in Physiologically Based Pharmacokinetic Modeling to Support Clinical Pharmacology Regulatory Decision-Making.